We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $9.37B
1-Year Est. Return 36.4%
This Fund
S&P 500
This Quarter Est. Return
+9.21%
1 Year Est. Return
+36.4%
3 Year Est. Return
+114.29%
5 Year Est. Return
+137.63%
10 Year Est. Return
+535.77%
AUM
$4.04B
AUM Growth
+$368M
Cap. Flow
+$68.3M
Cap. Flow %
1.69%
Top 10 Hldgs %
14.84%
Holding
1,360
New
108
Increased
584
Reduced
484
Closed
87

Top Buys

Rank Stock Value
1
DOCU
DocuSign
DOCU
+$4.67M
2
ADBE icon
Adobe
ADBE
+$4.33M
3
PWR icon
Quanta Services
PWR
+$3.93M
4
SPYD icon
State Street SPDR Portfolio S&P 500 High Dividend ETF
SPYD
+$3.61M
5
BMY icon
Bristol-Myers Squibb
BMY
+$3.61M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$6.53M
2
AAPL icon
Apple
AAPL
+$5.68M
3
IHI icon
iShares US Medical Devices ETF
IHI
+$4.6M
4
IYC icon
iShares US Consumer Discretionary ETF
IYC
+$4.11M
5
STZ icon
Constellation Brands
STZ
+$3.98M

Sector Composition

Rank Sector Weight
1 Technology 14.02%
2 Healthcare 12.17%
3 Financials 11.29%
4 Consumer Discretionary 8.82%
5 Industrials 8.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRK icon
26
Merck
MRK
$318B
$25.9M 0.64%
298,806
-10,839
-4% -$890K
COST icon
27
Costco
COST
$420B
$25.8M 0.64%
87,693
+2,241
+3% +$666K
BABA icon
28
Alibaba
BABA
$308B
$25.6M 0.63%
120,502
+17,429
+17% +$3.27M
GILD icon
29
Gilead Sciences
GILD
$165B
$24.7M 0.61%
380,093
-5,506
-1% -$359K
UNH icon
30
UnitedHealth
UNH
$370B
$24.4M 0.61%
83,121
+2,811
+4% +$735K
NVGS icon
31
Navigator Holdings
NVGS
$1.28B
$24.1M 0.6%
1,791,719
+101,360
+6% +$1.2M
BMY icon
32
Bristol-Myers Squibb
BMY
$132B
$23.4M 0.58%
364,055
+62,958
+21% +$3.61M
EPD icon
33
Enterprise Products Partners
EPD
$81.7B
$22.9M 0.57%
813,522
-27,689
-3% -$750K
PG icon
34
Procter & Gamble
PG
$339B
$22.1M 0.55%
176,879
+6,823
+4% +$835K
BA icon
35
Boeing
BA
$185B
$21.4M 0.53%
65,544
-8,269
-11% -$2.93M
XOM icon
36
ExxonMobil
XOM
$634B
$21.3M 0.53%
304,548
-16,279
-5% -$1.13M
INTC icon
37
Intel
INTC
$513B
$21.1M 0.52%
352,500
-22,508
-6% -$1.26M
HON icon
38
Honeywell
HON
$78B
$20.9M 0.52%
125,425
+11,937
+11% +$1.95M
PEP icon
39
PepsiCo
PEP
$190B
$20.7M 0.51%
151,716
+2,438
+2% +$332K
MTUM icon
40
iShares MSCI USA Momentum Factor ETF
MTUM
$26.2B
$20.7M 0.51%
164,581
-31,685
-16% -$3.84M
SBUX icon
41
Starbucks
SBUX
$120B
$20.5M 0.51%
233,394
+39,166
+20% +$3.34M
C icon
42
Citigroup
C
$226B
$19.9M 0.49%
249,201
-5,388
-2% -$398K
CVX icon
43
Chevron
CVX
$366B
$19.7M 0.49%
163,237
-2,610
-2% -$307K
WMT icon
44
Walmart Inc
WMT
$890B
$19.2M 0.48%
484,554
+4,341
+0.9% +$172K
MDT icon
45
Medtronic
MDT
$112B
$18.9M 0.47%
166,531
+20,044
+14% +$2.2M
AFL icon
46
Aflac
AFL
$62.6B
$18.9M 0.47%
356,933
+16,475
+5% +$874K
ZTS icon
47
Zoetis
ZTS
$30B
$18.3M 0.45%
138,170
+6,269
+5% +$779K
MA icon
48
Mastercard
MA
$493B
$18.2M 0.45%
61,054
+799
+1% +$225K
NEE icon
49
NextEra Energy
NEE
$177B
$18.2M 0.45%
300,784
+11,928
+4% +$696K
CMCSA icon
50
Comcast
CMCSA
$90B
$17.6M 0.44%
391,570
+73,875
+23% +$3.29M
1
2
3 4 5

Similar funds

AC
Allstate Corporation Northbrook, Illinois $9.35B AUM 16.13% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
PVI
Partners Value Investments Hamilton, Bermuda $9.34B AUM 12.2% 1-Year Est. Return
WPL
WINDACRE PARTNERSHIP LLC Houston, Texas $9.34B AUM 17.41% 1-Year Est. Return
IAA
Independent Advisor Alliance Charlotte, North Carolina $9.32B AUM 33.19% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
SIM
SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return

Oppenheimer & Co's Q4 2019 Portfolio in Review

As of Q4 2019, Oppenheimer & Co held 1,360 positions worth $4.04B, up 10% from $3.67B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Oppenheimer & Co's Q4 2019 filing shows 108 new, 584 increased, 484 reduced and 87 closed positions. Its largest new stake was CAE Inc. Common Shares: 78,310 shares worth $2.07M. The largest sale was Celgene Corp, an estimated $6.53M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Financials.

  • Oppenheimer & Co's largest Q4 2019 buy was CAE Inc. Common Shares: 78,310 shares worth $2.07M.
  • Oppenheimer & Co added most to DocuSign in Q4 2019, an estimated $4.67M increase.
  • Oppenheimer & Co's biggest Q4 2019 reduction was Apple, cutting an estimated $5.68M.
  • Oppenheimer & Co fully exited Celgene Corp in Q4 2019, selling an estimated $6.53M.
  • Oppenheimer & Co's ten largest holdings make up 15% of its $4.04B portfolio in Q4 2019.
  • Oppenheimer & Co opened 108 new positions and closed 87 in Q4 2019.
  • Oppenheimer & Co's portfolio value rose 10% quarter-over-quarter to $4.04B.

Based on Oppenheimer & Co's 13F filing for Q4 2019, filed 7 Feb 2020.